Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Atara Biotherapeutics (ATRA) Enterprise Value (2022 - 2025)

Historic Enterprise Value for Atara Biotherapeutics (ATRA) over the last 4 years, with Q3 2025 value amounting to -$13.7 million.

  • Atara Biotherapeutics' Enterprise Value rose 7959.19% to -$13.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$13.7 million, marking a year-over-year increase of 7959.19%. This contributed to the annual value of -$42.5 million for FY2024, which is 1784.24% up from last year.
  • As of Q3 2025, Atara Biotherapeutics' Enterprise Value stood at -$13.7 million, which was up 7959.19% from -$22.3 million recorded in Q2 2025.
  • Atara Biotherapeutics' 5-year Enterprise Value high stood at -$13.7 million for Q3 2025, and its period low was -$331.3 million during Q2 2022.
  • For the 4-year period, Atara Biotherapeutics' Enterprise Value averaged around -$126.4 million, with its median value being -$67.2 million (2024).
  • Per our database at Business Quant, Atara Biotherapeutics' Enterprise Value soared by 1784.24% in 2024 and then surged by 7959.19% in 2025.
  • Over the past 4 years, Atara Biotherapeutics' Enterprise Value (Quarter) stood at -$242.8 million in 2022, then soared by 78.7% to -$51.7 million in 2023, then grew by 17.84% to -$42.5 million in 2024, then soared by 67.73% to -$13.7 million in 2025.
  • Its last three reported values are -$13.7 million in Q3 2025, -$22.3 million for Q2 2025, and -$14.0 million during Q1 2025.